Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases

被引：12

作者：

Alberton F. ^{[1
]}

Corain M. ^{[1
]}

Garofano A. ^{[1
]}

Pangallo L. ^{[1
]}

Valore A. ^{[1
]}

Zanella V. ^{[1
]}

Adani R. ^{[1
,2
]}

机构：

[1] Department of Hand Surgery, University Hospital of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, Verona

[2] U.O.C. Chirurgia della Mano, Policlinico G.B. Rossi Azienda Ospedaliera Universitaria Integrata Verona, p.zzle L.A. Scuro, 10, Verona

来源：

MUSCULOSKELETAL SURGERY | 2014年 / 98卷 / 3期

关键词：

Clostridium Histolyticum; Collagenase injection; Dupuytren; Nonsurgical treatment;

D O I：

10.1007/s12306-013-0304-x

中图分类号：

学科分类号：

摘要：

Conclusions: The use of collagenase appears to be an effective and safe method for the treatment of Dupuytren’s contracture. Therapeutic success was achieved in a significant percentage of patients. The incidence of side effects was higher, but they were local reactions of short duration. The use of a single collagenase vial in patients treated in day surgery appears more cost-effective than surgery.; Background: Dupuytren’s disease (DD) is a fibroproliferative pathology that affects the palmar aponeurosis causing the development of nodules and collagen cords and the progressive flexion of the fingers. The standard procedure is surgical fasciectomy, followed by high recurrence rates. Collagenase Clostridium histolyticum (CCH) injection represents an innovative noninvasive approach to the treatment of DD. This prospective study was designed to examine the efficacy and safety of CCH injection performed in the outpatient, using local anesthesia.; Results: About 67.5 % of patients obtained a clinical success. At 6 months, a further 7.5 % attained the same result. The mean contracture of treated joints was 5.3º for MP and 6.8° for PIP joints. Twenty-three patients had one or more mild-to-moderate side effects.; Materials and methods: Forty patients [32 metacarpophalangeal (MP), 8 proximal interphalangeal (PIP)] with Dupuytren’s contracture of at least 20° for MP joint and any degree for PIP joint were included. The mean age was 66. All joints were treated with a single vial of collagenase injection and manual breaking of the cord 24 h after. All adverse effects (AEs) were monitored. Patients were checked 7, 30, 90, and 180 days after the injection. Primary endpoint was a reduction in digit contracture within 0°–5° of normal extension. Secondary endpoints were the improvement of range of motion, the evaluation of AEs incidence, and cost-effectiveness of collagenase treatment. © 2013, Istituto Ortopedico Rizzoli.

引用

页码：225 / 232

页数：7

共 21 条

[1]

Rayan G.M., Dupuytren’s disease: anatomy, pathology, presentation, and treatment, J Bone Joint Surg Am, 89, 1, pp. 189-198, (2007)

[2]

Shaw R.B., Chong A.K., Zhang A., Hentz V.R., Chang J., Dupuytren’s disease: history, diagnosis, and treatment, Plast Reconstr Surg, 120, 3, pp. 44-54, (2007)

[3]

Smith A.C., Diagnosis and indications for surgical treatment, Hand Clin, 7, pp. 635-642, (1991)

[4]

Mafi R., Hindocha S., Khan W., Recent surgical and medical advances in the treatment of Dupuytren’s disease—a systematic review of the literature, Open Orthop J, 6, pp. 77-82, (2012)

[5]

Crean S.M., Gerber R.A., Le Graverand M.P., Boyd D.M., Cappelleri J.C., The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies, J Hand Surg Eur Vol, 36, pp. 396-407, (2011)

[6]

Witthaut J., Jones G., Skrepnik N., Kushner H., Houston A., Lindau T.R., Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies, J Hand Surg, 38, 1, pp. 2-11, (2013)

[7]

Chen N.C., Srinivasan R.C., Shauver M.J., Chung K.C., A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture, Hand, 6, 3, pp. 250-255, (2011)

[8]

Werker P.M., Pess G.M., van Rijssen A.L., Denkler K., Correction of contracture and relapse rates of Dupuytren contracture following invasive treatment: the importance of clear definitions, J Hand Surg Am, 37, 10, pp. 2095-2105, (2012)

[9]

Tripoli M., Cordova A., Moschella F., The ‘‘Jacobsen Flap’’ technique: a safe, simple surgical procedure to treat Dupuytren disease of the little finger in advanced stage, Tech Hand Up Extrem Surg, 14, pp. 173-177, (2010)

[10]

Jacobsen K., Holst-Nielsen F., A modified Mc Cash operation for Dupuytren’s contracture, Scand J Plast Reconstr Surg, 11, 3, pp. 231-233, (1977)

← 1 2 3 →